Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037208 | SCV000060865 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Glu161Lys in Exon 06 of ATP6V1B1: This variant is not expected to have clinical significance because it has been identified in 2.4% (90/3738) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs114234874). |
Eurofins Ntd Llc |
RCV000037208 | SCV000231627 | benign | not specified | 2015-01-20 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000299123 | SCV000431634 | benign | Renal tubular acidosis with progressive nerve deafness | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000037208 | SCV000730650 | benign | not specified | 2017-11-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Counsyl | RCV000299123 | SCV000790101 | benign | Renal tubular acidosis with progressive nerve deafness | 2017-03-06 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000991559 | SCV001143091 | benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000991559 | SCV001717812 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000299123 | SCV001761695 | benign | Renal tubular acidosis with progressive nerve deafness | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000037208 | SCV002050928 | benign | not specified | 2023-03-15 | criteria provided, single submitter | clinical testing | Variant summary: ATP6V1B1 c.481G>A (p.Glu161Lys) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.03 in 251352 control chromosomes in the gnomAD database, including 191 homozygotes. The observed variant frequency is approximately 27-fold of the estimated maximal expected allele frequency for a pathogenic variant in ATP6V1B1 causing Renal Tubular Acidosis With Progressive Nerve Deafness phenotype (0.0011), strongly suggesting that the variant is benign. To our knowledge, no penetrant association of c.481G>A with Renal Tubular Acidosis With Progressive Nerve Deafness has been reported. Nine submitters have provided clinical-significance assessments for this variant to ClinVar after 2014. The majority classified the variant as benign (n=8), and one classified it as likely pathogenic. Based on the evidence outlined above, the variant was classified as benign. |
Natera, |
RCV000299123 | SCV001452519 | benign | Renal tubular acidosis with progressive nerve deafness | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000037208 | SCV001930606 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000991559 | SCV001959160 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Cyto- |
RCV000299123 | SCV002102803 | likely pathogenic | Renal tubular acidosis with progressive nerve deafness | 2022-03-07 | flagged submission | clinical testing |